For people with weakened immune systems, the question of how to stay safe from COVID-19 is especially urgent. A new report from the United States has taken a closer look at this exact problem, reviewing what we know about preventing and treating the virus in immunocompromised individuals. The report doesn't present new research findings or clinical trial results. Instead, it serves as a focused examination of the existing landscape for a group that remains at higher risk. Because this is a review and not a new study, it doesn't offer breakthrough data or clear-cut recommendations. It highlights the ongoing need for tailored strategies but doesn't specify what those are or how well they work. The lack of reported results means we're still waiting for concrete evidence on the most effective approaches for this community.
Measures for COVID-19 prevention and treatment in immunocompromised persons reviewedHow can immunocompromised people protect themselves from COVID-19?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: Review on COVID-19 in immunocompromised lacks specific evidence.
This publication is a review concerning the prevention and treatment of SARS-CoV-2 infection, specifically focused on persons who are immunocompromised. The setting is the United States. The specific study type, phase, sample size, and follow-up duration are not reported. The intervention or exposure, comparator, and primary or secondary outcomes are also not detailed. No main results, including efficacy or effectiveness data, are provided. Safety and tolerability information, including adverse events, serious adverse events, and discontinuations, are not reported. Key limitations of the evidence are not specified. The funding sources and potential conflicts of interest are not reported. The practice relevance and any notes on causality or certainty are not provided. This summary describes a publication on a clinically important topic but does not convey specific evidence to guide practice.
What this means for you:
A report reviews COVID-19 care for immunocompromised people, but new answers are still needed. More on SARS-CoV-2 infection
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders
Clozapine users faced higher risk of severe COVID-19 in large study
A meta-analysis of 155,945 outpatients with severe mental disorders found that clozapine users had a higher rate of SARS-CoV-2 infection com…
A massive analysis of over 155,000 people found that those taking clozapine had higher rates of infection and worse outcomes from COVID-19.
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial
Metformin Cuts Long Covid Risk by 40%
This randomized controlled trial in 1323 non-hospitalized adults with SARS-CoV-2 infection evaluated metformin, fluvoxamine, or ivermectin v…
A common diabetes pill taken early in Covid infection cuts the odds of developing long-term symptoms by 40%, offering new hope for millions.
Observational cohort study on SARS-CoV-2 evolution in immunocompromised patients
Long COVID Virus Changes Shape Inside Severely Ill Patients, Study Finds
This observational cohort study analyzed longitudinal SARS-CoV-2 genomes from 91 immunocompromised patients with COVID-19.
When the virus lingers too long in very sick patients, it changes in unpredictable ways, highlighting the need for stronger treatments.
Systematic review synthesizes immune and genetic factors in African SARS-CoV-2 populations
Why Africa saw milder COVID-19
This narrative synthesis reviews 40 studies from African settings regarding SARS-CoV-2 infection.
Africa saw milder COVID-19 because unique genes and immune defenses helped people fight the virus without getting severely sick.
View Original Abstract ↓
This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
New Asthma Drug Cuts Attacks Without Recent Crisis
Related in Allergy & Immunology
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
FDA Approves Exdensur for Add-On Maintenance Treatment of Severe Eosinophilic Asthma
FDA approves new long-acting shot Exdensur for severe asthma.
FDA approved Exdensur (IL-5 antagonist) for add-on maintenance treatment of severe eosinophilic asthma in patients aged 12 years and older. …
The FDA approved Exdensur as an add-on treatment for severe asthma in people 12 and older. It is given as a shot every six months. This new …
CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
Immune Cells and Signaling Pathways Influence Bone Health in Osteoporosis
This narrative review synthesizes the role of CD8+ T cells and related cytokines like IFN-gamma, CCL5, and IL-33 in bone metabolism. The aut…
New research highlights how specific immune cells and signaling pathways may play a dual role in protecting or promoting bone loss in osteop…
From Other Specialties
Risk factors and protective behaviors identified for myopia in Chinese school students
Factors that increase or decrease myopia risk in students
This meta-analysis examined various behavioral and genetic risk factors associated with myopia among primary and secondary school students. …
New data from over 1.8 million students reveals how screen time, posture, and outdoor habits impact eye health and the development of nearsi…
Topical emollient application improves skin integrity and topical oil reduces sepsis risk in preterm neonates
Topical Oil May Reduce Sepsis Risk in Preterm Infants
This meta-analysis of 5,586 preterm neonates found that topical emollients significantly improved skin integrity (SMD -1.11). While overall …
Applying topical oils may improve skin health and reduce sepsis risk in preterm babies, according to a review of over 5,000 infants.
Once-weekly basal insulin improves HbA1c by 0.09% and time in range over daily regimens
Weekly insulin offers easier management for people with type 2 diabetes
This meta-analysis of 14 randomized controlled trials involving 8,487 subjects found that once-weekly basal insulin analogs provide superior…
A new review of clinical trials shows weekly insulin can manage blood sugar as well as daily shots while reducing the number of injections.
Naive pooling of RCTs and non-randomized studies in network meta-analyses is common and problematic
Improving the Quality of Evidence Used in Medical Network Meta-Analyses
This protocol describes a meta-epidemiological study that will examine how often network meta-analyses naively pool randomized and non-rando…
Researchers plan to check if medical studies are mixing different types of evidence without proper adjustments, which could affect treatment…